Indiana is a national life sciences leader in the areas of exports, employment concentration, job growth and FDA filings according to the most recent report by BioCrossroads and Battelle.
Indiana is home to more than 1,000 businesses in the medical device, pharmaceutical, drug development, diagnostic and agriculture-biotech sectors. In fact, Eli Lilly and Company CEO John C. Lechleiter cited Indiana as a model for the nation: "The successful effort to build a thriving life sciences hub in Indiana ... is reason to believe that our country can overcome the challenges we confront today."
Eli Lilly and Company, Biomet, Cook Group Inc., Roche Diagnostics and Zimmer are just a few of Indiana's Life Science leaders. Indiana also boasts the second-largest medical school in the United States, the Indiana University School of Medicine. Indiana is also home to the Indiana University Emerging Technologies Center, a highly successful business incubator which houses many biosciences companies.
Indiana's life sciences industry succeeds through a collaboration of partnerships between industry, academia and government which creates new jobs and economic growth.
BioCrossroads was formed to capitalize on Indiana’s strong foundation in the life sciences by attracting new business opportunities, intellectual property and capital to the life sciences industry.
The Indiana Health Industry Forum works to create an environment where Indiana is a premier location for the creation and growth of health industry enterprises.
Indiana Health Industry Forum
The Indiana University Kelley School of Business Healthcare and Life Sciences Initiative's goal is to widen and deepen Kelley's life sciences brand, and to make Kelley the place to study and to hire business students for the life sciences and healthcare industries.
IU Kelley Center for the Business of Life Sciences